ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹937 Cr | ₹784 Cr | ₹703 Cr | ₹645 Cr | ₹544 Cr |
What is the latest Net Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹937 Cr |
| Mar2025 | ₹784 Cr |
| Mar2024 | ₹703 Cr |
| Mar2023 | ₹645 Cr |
| Mar2022 | ₹544 Cr |
How is Net Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹937 Cr | 19.55 | |
| Mar2025 | ₹784 Cr | 11.41 | |
| Mar2024 | ₹703 Cr | 9.13 | |
| Mar2023 | ₹645 Cr | 18.48 | |
| Mar2022 | ₹544 Cr | - | |
Compare Net Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,192.6 Cr | 3.3% | 12.3% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.3% |
12.3% |
-12.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses